Vistagen Therapeutics (VTGN) Other Accumulated Expenses (2012 - 2023)
Vistagen Therapeutics' Other Accumulated Expenses came in at $10,000 for fiscal Q1 2024 (quarter ended Jun 30, 2023), up 85.2% from $5,400 a year earlier.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Other Accumulated Expenses (2012 - 2023) Analysis & Trends
At the end of FY2022 (ended Mar 31, 2022), Vistagen Therapeutics' Other Accumulated Expenses was $32,700, up 17.6% from FY2021.
- Other Accumulated Expenses has increased in each of the last four fiscal years, with a five-year compound annual growth rate of 55.5% (FY2017 to FY2022).
- Going back by fiscal year, Other Accumulated Expenses was $27,800 in FY2021 (+22.5%), $22,700 in FY2020 (+238.8%), $6,700 in FY2019 (+148.1%) and $2,700 in FY2018 (-25.0%).
- The fiscal Q1 2024 figure represents the highest quarterly Other Accumulated Expenses since fiscal Q4 2022.
- Year-over-year, Other Accumulated Expenses increased in three of the last four quarters, with growth averaging 71.6%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in fiscal Q2 2022 (growth of 281.7%), and the weakest in fiscal Q2 2023 (a decline of 98.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Vistagen Therapeutics | 12.43 Mn | 12.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 10,000.00 |
| Sep 30, 2022 | 1,200.00 |
| Jun 30, 2022 | 5,400.00 |
| Mar 31, 2022 | 32,700.00 |
| Sep 30, 2021 | 62,600.00 |
| Mar 31, 2021 | 27,800.00 |
| Dec 31, 2020 | 5,500.00 |
| Sep 30, 2020 | 16,400.00 |
| Jun 30, 2020 | 20,700.00 |
| Mar 31, 2020 | 22,700.00 |
| Dec 31, 2019 | 7,900.00 |
| Sep 30, 2019 | 7,200.00 |
| Jun 30, 2019 | 7,700.00 |
| Mar 31, 2019 | 6,700.00 |
| Dec 31, 2018 | 8,800.00 |
| Sep 30, 2018 | 5,500.00 |
| Jun 30, 2018 | 3,500.00 |
| Mar 31, 2018 | 2,700.00 |
| Dec 31, 2017 | 3,100.00 |
| Sep 30, 2017 | 10,000.00 |
API Access
Vistagen Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();